Cargando…
Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV
We evaluated the psychometric properties of a modified version of the Vaccine Hesitancy Scale (VHS) among people with HIV (PWH) for COVID-19 vaccination in a cross-sectional study in the US. Self-report data from an online questionnaire were collected from a sample of N = 175 PWH. Participants were...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210509/ https://www.ncbi.nlm.nih.gov/pubmed/34138378 http://dx.doi.org/10.1007/s10461-021-03350-5 |
_version_ | 1783709326736621568 |
---|---|
author | Rodriguez, Violeta J. Alcaide, Maria L. Salazar, Ana S. Montgomerie, Emily K. Maddalon, Marissa J. Jones, Deborah L. |
author_facet | Rodriguez, Violeta J. Alcaide, Maria L. Salazar, Ana S. Montgomerie, Emily K. Maddalon, Marissa J. Jones, Deborah L. |
author_sort | Rodriguez, Violeta J. |
collection | PubMed |
description | We evaluated the psychometric properties of a modified version of the Vaccine Hesitancy Scale (VHS) among people with HIV (PWH) for COVID-19 vaccination in a cross-sectional study in the US. Self-report data from an online questionnaire were collected from a sample of N = 175 PWH. Participants were surveyed in English or Spanish regarding attitudes towards COVID-19 vaccination using the adapted VHS. Participants were on average 51.55 years of age (SD = 13.90) 55% were women. The reliability of the scale was acceptable (α = 0.72). An exploratory factor analysis showed that “Lack of confidence” and “Risks” explained 45.55% and 12.31% of the variance. Related items showed expected associations with these factors, supporting construct validity. Results illustrate that the modified VHS for COVID-19 vaccination has adequate psychometric properties. We replicated the original factor structure of the VHS and demonstrated adequate internal consistency and construct validity. Validated tools are essential to guide vaccination policy and campaigns towards populations at risk. |
format | Online Article Text |
id | pubmed-8210509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-82105092021-06-17 Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV Rodriguez, Violeta J. Alcaide, Maria L. Salazar, Ana S. Montgomerie, Emily K. Maddalon, Marissa J. Jones, Deborah L. AIDS Behav Original Paper We evaluated the psychometric properties of a modified version of the Vaccine Hesitancy Scale (VHS) among people with HIV (PWH) for COVID-19 vaccination in a cross-sectional study in the US. Self-report data from an online questionnaire were collected from a sample of N = 175 PWH. Participants were surveyed in English or Spanish regarding attitudes towards COVID-19 vaccination using the adapted VHS. Participants were on average 51.55 years of age (SD = 13.90) 55% were women. The reliability of the scale was acceptable (α = 0.72). An exploratory factor analysis showed that “Lack of confidence” and “Risks” explained 45.55% and 12.31% of the variance. Related items showed expected associations with these factors, supporting construct validity. Results illustrate that the modified VHS for COVID-19 vaccination has adequate psychometric properties. We replicated the original factor structure of the VHS and demonstrated adequate internal consistency and construct validity. Validated tools are essential to guide vaccination policy and campaigns towards populations at risk. Springer US 2021-06-17 2022 /pmc/articles/PMC8210509/ /pubmed/34138378 http://dx.doi.org/10.1007/s10461-021-03350-5 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Paper Rodriguez, Violeta J. Alcaide, Maria L. Salazar, Ana S. Montgomerie, Emily K. Maddalon, Marissa J. Jones, Deborah L. Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV |
title | Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV |
title_full | Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV |
title_fullStr | Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV |
title_full_unstemmed | Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV |
title_short | Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV |
title_sort | psychometric properties of a vaccine hesitancy scale adapted for covid-19 vaccination among people with hiv |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210509/ https://www.ncbi.nlm.nih.gov/pubmed/34138378 http://dx.doi.org/10.1007/s10461-021-03350-5 |
work_keys_str_mv | AT rodriguezvioletaj psychometricpropertiesofavaccinehesitancyscaleadaptedforcovid19vaccinationamongpeoplewithhiv AT alcaidemarial psychometricpropertiesofavaccinehesitancyscaleadaptedforcovid19vaccinationamongpeoplewithhiv AT salazaranas psychometricpropertiesofavaccinehesitancyscaleadaptedforcovid19vaccinationamongpeoplewithhiv AT montgomerieemilyk psychometricpropertiesofavaccinehesitancyscaleadaptedforcovid19vaccinationamongpeoplewithhiv AT maddalonmarissaj psychometricpropertiesofavaccinehesitancyscaleadaptedforcovid19vaccinationamongpeoplewithhiv AT jonesdeborahl psychometricpropertiesofavaccinehesitancyscaleadaptedforcovid19vaccinationamongpeoplewithhiv |